| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |